Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates

被引:31
|
作者
Portnoy, Allison [1 ]
Vaughan, Kelsey [2 ]
Clarke-Deelder, Emma [3 ]
Suharlim, Christian [1 ,4 ]
Resch, Stephen C. [1 ]
Brenzel, Logan [5 ]
Menzies, Nicolas A. [1 ,3 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA
[2] Thinkwell, Washington, DC USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA
[4] Management Sci Hlth, Boston, MA USA
[5] Bill & Melinda Gates Fdn, Seattle, WA USA
基金
比尔及梅琳达.盖茨基金会;
关键词
ROUTINE IMMUNIZATION; EXPANDED PROGRAM; SERVICE DELIVERY; HEALTH DISTRICT; VACCINE; COVERAGE; INCOME;
D O I
10.1007/s40273-020-00930-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background To plan for the financial sustainability of immunization programs and make informed decisions to improve immunization coverage and equity, decision-makers need to know how much these programs cost beyond the cost of the vaccine. Non-vaccine delivery cost estimates can significantly influence the cost-effectiveness estimates used to allocate resources at the country level. However, many low- and middle-income countries (LMICs) do not have immunization delivery unit cost estimates available, or have estimates that are uncertain, unreliable, or old. We undertook a Bayesian evidence synthesis to generate country-level estimates of immunization delivery unit costs for LMICs. Methods From a database of empirical immunization costing studies, we extracted estimates of the delivery cost per dose for routine childhood immunization services, excluding vaccine costs. A Bayesian meta-regression model was used to regress delivery cost per dose estimates, stratified by cost category, against a set of predictor variables including country-level [gross domestic product per capita, reported diphtheria-tetanus-pertussis third dose coverage (DTP3), population, and number of doses in the routine vaccination schedule] and study-level (study year, single antigen or programmatic cost per dose, and financial or economic cost) predictors. The fitted prediction model was used to generate standardized estimates of the routine immunization delivery cost per dose for each LMIC for 2009-2018. Alternative regression models were specified in sensitivity analyses. Results We estimated the prediction model using the results from 29 individual studies, covering 24 countries. The predicted economic cost per dose for routine delivery of childhood vaccines (2018 US dollars), not including the price of the vaccine, was $1.87 (95% uncertainty interval $0.64-4.38) across all LMICs. By individual cost category, the programmatic economic cost per dose for routine delivery of childhood vaccines was $0.74 ($0.26-1.70) for labor, $0.26 ($0.08-0.67) for supply chain, $0.22 ($0.06-0.57) for capital, and $0.65 ($0.20-1.66) for other service delivery costs. Conclusions Accurate immunization delivery costs are necessary for assessing the cost-effectiveness and strategic planning needs of immunization programs. The cost estimates from this analysis provide a broad indication of immunization delivery costs that may be useful when accurate local data are unavailable.
引用
收藏
页码:995 / 1005
页数:11
相关论文
共 47 条
  • [1] PRODUCING STANDARDIZED COUNTRY-LEVEL IMMUNIZATION DELIVERY UNIT COST ESTIMATES
    Portnoy, Allison
    Vaughan, Kelsey
    Ozaltin, Annette
    Clarke, Emma
    Suharlim, Christian
    Resch, Stephen C.
    Menzies, Nicolas A.
    MEDICAL DECISION MAKING, 2020, 40 (01) : E196 - E197
  • [2] Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates
    Allison Portnoy
    Kelsey Vaughan
    Emma Clarke-Deelder
    Christian Suharlim
    Stephen C. Resch
    Logan Brenzel
    Nicolas A. Menzies
    PharmacoEconomics, 2020, 38 : 995 - 1005
  • [3] Global cost of child survival: estimates from country-level validation
    van Ekdom, Liselore
    Stenberg, Karin
    Scherpbier, Robert W.
    Niessen, Louis W.
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2011, 89 (04) : 267 - 277
  • [4] COUNTRY-LEVEL COST-EFFECTIVENESS THRESHOLD: INITIAL ESTIMATES IN REPUBLIC OF BELARUS
    Kozhanova, I
    Sachek, M.
    VALUE IN HEALTH, 2018, 21 : S178 - S179
  • [5] Country-level social cost of carbon
    Katharine Ricke
    Laurent Drouet
    Ken Caldeira
    Massimo Tavoni
    Nature Climate Change, 2018, 8 : 895 - 900
  • [6] Country-level social cost of carbon
    Ricke, Katharine
    Drouet, Laurent
    Caldeira, Ken
    Tavoni, Massimo
    NATURE CLIMATE CHANGE, 2018, 8 (10) : 895 - +
  • [7] Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates
    Edney, Laura C.
    Lomas, James
    Karnon, Jonathan
    Vallejo-Torres, Laura
    Stadhouders, Niek
    Siverskog, Jonathan
    Paulden, Mike
    Edoka, Ijeoma P.
    Ochalek, Jessica
    PHARMACOECONOMICS, 2022, 40 (01) : 31 - 43
  • [8] Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates
    Laura C. Edney
    James Lomas
    Jonathan Karnon
    Laura Vallejo-Torres
    Niek Stadhouders
    Jonathan Siverskog
    Mike Paulden
    Ijeoma P. Edoka
    Jessica Ochalek
    PharmacoEconomics, 2022, 40 : 31 - 43
  • [9] Author Correction: Country-level social cost of carbon
    Katharine Ricke
    Laurent Drouet
    Ken Caldeira
    Massimo Tavoni
    Nature Climate Change, 2019, 9 (7) : 567 - 567
  • [10] Global and country-level estimates of human population at high altitude
    Tremblay, Joshua C.
    Ainslie, Philip N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (18)